A Single-arm, Open, Exploratory Clinical Study of Tislelizumab Combined With Radiotherapy as the Second-line Treatment of Advanced Biliary Malignant Tumors
Latest Information Update: 05 Apr 2023
At a glance
- Drugs Tislelizumab (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- 05 May 2021 New trial record